Real-Time Quantitative PCR

TS Tijana Subotički
OA Olivera Mitrović Ajtić
BB Bojana B. Beleslin-Čokić
RN Ronny Nienhold
MD Miloš Diklić
DD Dragoslava Djikić
DL Danijela Leković
TB Tanja Bulat
DM Dragana Marković
MG Mirjana Gotić
CN Constance T. Noguchi
AS Alan N. Schechter
RS Radek C. Skoda
Vladan P. Čokić
ask Ask a question
Favorite

Quantitative real-time PCR analyses of human VEGF gene was performed using a LightCycler 480 (Roche Diagnostics, Roche Applied Science, Mannheim, Germany) and Taqman oligonucleotide probe 5 CCA AGT GGT CCC AGG CTG CAC C 3 and forward 5 TTG CTG CTC TAC CTC CAC CAT 3 and reverse 5 CAC TTC GTG ATG ATT CTG CCC 3 primers. The oligonucleotide probes were fluorescently labeled on the 5 end with FAM (6-carboxy fluorescein) and on the 3 end with BlackBerry Quencher (BBQ). Quantitative real-time PCR analyses of human HIF-1α gene was performed using oligonucleotide probe 5 AGC AAC AGG GAA AGC GTG GCT 3 and forward 5 GGC AGG AAG ATT GTC ATG GAC 3 and reverse 5 TCT GTC TGT CAC ATG GGT GAT GAA 3 primers (TIB MOLBIOL GmbH, Berlin, Germany). Real-time quantitative PCR of eNOS gene was performed on a Mastercycler EP RealPlex (Eppendorf AG, Hamburg, Germany) using the Maxima SYBR Green/ROX qPCR master mix (Thermo Scientific, Cambridge, UK) and forward: 5 CGG CAT CAC CAG GAA GAA GA 3 and reverse 5 GCC ATC ACC GTG CCC AT 3 primers. β-actin was used as an internal control for normalization of the examined angiogenic factors. Real-time PCR was performed in granulocytes of total 83 MPN patients, but because of overlapping (samples from the same patient): HIF-1α was evaluated in 50 samples (20 PV, 15 ET, 15 PMF, plus 6 controls), VEGF in 52 samples (20 PV, 16 ET, 16 PMF, plus 6 controls) and eNOS in 58 samples (20 PV, 23 ET, 15 PMF, plus 6 controls). Real-time PCR was performed in CD34+ cells of total 57 MPN patients, but because of overlapping: HIF-1α was evaluated in 36 samples (16 PV, 11 ET, 9 PMF, plus 5 controls), VEGF in 44 samples (22 PV, 11 ET, 11 PMF, plus 5 controls), and eNOS in 39 samples (15 PV, 15 ET, 9 PMF, plus 5 controls).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A